NextCure (NASDAQ:NXTC – Get Free Report) and NGM Biopharmaceuticals (NASDAQ:NGM – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings. Insider & Institutional Ownership 47.8% of NextCure shares […]
NextCure, Inc. (NASDAQ:NXTC – Get Free Report)’s share price traded up 0.9% during trading on Monday . The company traded as high as $1.20 and last traded at $1.12. 124,661 shares traded hands during trading, an increase of 88% from the average session volume of 66,242 shares. The stock had previously closed at $1.11. Analyst […]
HC Wainwright initiated coverage on shares of NextCure (NASDAQ:NXTC – Free Report) in a report issued on Tuesday morning, MarketBeat reports. The brokerage issued a buy rating and a $7.00 price objective on the stock. Separately, Needham & Company LLC reaffirmed a buy rating and set a $6.00 price target on shares of NextCure in […]